Nontricyclic antidepressants: Current trends in children and adolescents

Graham J. Emslie, John T. Walkup, Steven R. Pliszka, Monique Ernst

Research output: Contribution to journalArticle

Abstract

Objectives: First, to review the extant data on the safety and efficacy of the use of nontricyclic antidepressants in children and adolescents; second, to identify the main limitations of our current knowledge in this area; and third, to point to future research directions. Method: A Medline search and a review of previous scientific meetings were conducted; all available reports on the efficacy and safety of nontricyclic antidepressants in children and adolescents were critically reviewed. Results: As in adults, also in children nontricyclic antidepressants are potentially useful in treating a variety of psychiatric disorders. The data supporting their efficacy, however, are quite limited. Obsessive-compulsive disorder is the only psychiatric diagnosis for which pediatric use of selective serotonin reuptake inhibitors has been approved. One placebo-controlled study in children and adolescents with major depression supports the efficacy of fluoxetine. Other clinical trials of nontricyclic antidepressants in depressed adolescents are in progress. Available data indicate that the safety of these medications is good, at least in the short term. Conclusions: The potential usefulness of nontricyclic antidepressants for children and adolescents suffering from a range of disorders is considerable. While information from adults can suggest potential areas of possible efficacy in pediatric patients suffering from similar psychopathology, further research is essential to provide the necessary information on the efficacy, safety, and pharmacokinetics of these medications in children and adolescents.

Original languageEnglish (US)
Pages (from-to)517-528
Number of pages12
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume38
Issue number5
StatePublished - 1999

Fingerprint

Antidepressive Agents
Safety
Pediatrics
Fluoxetine
Obsessive-Compulsive Disorder
Serotonin Uptake Inhibitors
Psychopathology
Mental Disorders
Psychiatry
Pharmacokinetics
Placebos
Clinical Trials
Depression
Research

Keywords

  • Efficacy
  • Monoamine oxidase inhibitors
  • Psychopharmacology
  • Safety
  • Selective serotonin reuptake inhibitors

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Nontricyclic antidepressants : Current trends in children and adolescents. / Emslie, Graham J.; Walkup, John T.; Pliszka, Steven R.; Ernst, Monique.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 38, No. 5, 1999, p. 517-528.

Research output: Contribution to journalArticle

Emslie, Graham J. ; Walkup, John T. ; Pliszka, Steven R. ; Ernst, Monique. / Nontricyclic antidepressants : Current trends in children and adolescents. In: Journal of the American Academy of Child and Adolescent Psychiatry. 1999 ; Vol. 38, No. 5. pp. 517-528.
@article{86deaf689f8147a3a41a1977e2d3e39f,
title = "Nontricyclic antidepressants: Current trends in children and adolescents",
abstract = "Objectives: First, to review the extant data on the safety and efficacy of the use of nontricyclic antidepressants in children and adolescents; second, to identify the main limitations of our current knowledge in this area; and third, to point to future research directions. Method: A Medline search and a review of previous scientific meetings were conducted; all available reports on the efficacy and safety of nontricyclic antidepressants in children and adolescents were critically reviewed. Results: As in adults, also in children nontricyclic antidepressants are potentially useful in treating a variety of psychiatric disorders. The data supporting their efficacy, however, are quite limited. Obsessive-compulsive disorder is the only psychiatric diagnosis for which pediatric use of selective serotonin reuptake inhibitors has been approved. One placebo-controlled study in children and adolescents with major depression supports the efficacy of fluoxetine. Other clinical trials of nontricyclic antidepressants in depressed adolescents are in progress. Available data indicate that the safety of these medications is good, at least in the short term. Conclusions: The potential usefulness of nontricyclic antidepressants for children and adolescents suffering from a range of disorders is considerable. While information from adults can suggest potential areas of possible efficacy in pediatric patients suffering from similar psychopathology, further research is essential to provide the necessary information on the efficacy, safety, and pharmacokinetics of these medications in children and adolescents.",
keywords = "Efficacy, Monoamine oxidase inhibitors, Psychopharmacology, Safety, Selective serotonin reuptake inhibitors",
author = "Emslie, {Graham J.} and Walkup, {John T.} and Pliszka, {Steven R.} and Monique Ernst",
year = "1999",
language = "English (US)",
volume = "38",
pages = "517--528",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Nontricyclic antidepressants

T2 - Current trends in children and adolescents

AU - Emslie, Graham J.

AU - Walkup, John T.

AU - Pliszka, Steven R.

AU - Ernst, Monique

PY - 1999

Y1 - 1999

N2 - Objectives: First, to review the extant data on the safety and efficacy of the use of nontricyclic antidepressants in children and adolescents; second, to identify the main limitations of our current knowledge in this area; and third, to point to future research directions. Method: A Medline search and a review of previous scientific meetings were conducted; all available reports on the efficacy and safety of nontricyclic antidepressants in children and adolescents were critically reviewed. Results: As in adults, also in children nontricyclic antidepressants are potentially useful in treating a variety of psychiatric disorders. The data supporting their efficacy, however, are quite limited. Obsessive-compulsive disorder is the only psychiatric diagnosis for which pediatric use of selective serotonin reuptake inhibitors has been approved. One placebo-controlled study in children and adolescents with major depression supports the efficacy of fluoxetine. Other clinical trials of nontricyclic antidepressants in depressed adolescents are in progress. Available data indicate that the safety of these medications is good, at least in the short term. Conclusions: The potential usefulness of nontricyclic antidepressants for children and adolescents suffering from a range of disorders is considerable. While information from adults can suggest potential areas of possible efficacy in pediatric patients suffering from similar psychopathology, further research is essential to provide the necessary information on the efficacy, safety, and pharmacokinetics of these medications in children and adolescents.

AB - Objectives: First, to review the extant data on the safety and efficacy of the use of nontricyclic antidepressants in children and adolescents; second, to identify the main limitations of our current knowledge in this area; and third, to point to future research directions. Method: A Medline search and a review of previous scientific meetings were conducted; all available reports on the efficacy and safety of nontricyclic antidepressants in children and adolescents were critically reviewed. Results: As in adults, also in children nontricyclic antidepressants are potentially useful in treating a variety of psychiatric disorders. The data supporting their efficacy, however, are quite limited. Obsessive-compulsive disorder is the only psychiatric diagnosis for which pediatric use of selective serotonin reuptake inhibitors has been approved. One placebo-controlled study in children and adolescents with major depression supports the efficacy of fluoxetine. Other clinical trials of nontricyclic antidepressants in depressed adolescents are in progress. Available data indicate that the safety of these medications is good, at least in the short term. Conclusions: The potential usefulness of nontricyclic antidepressants for children and adolescents suffering from a range of disorders is considerable. While information from adults can suggest potential areas of possible efficacy in pediatric patients suffering from similar psychopathology, further research is essential to provide the necessary information on the efficacy, safety, and pharmacokinetics of these medications in children and adolescents.

KW - Efficacy

KW - Monoamine oxidase inhibitors

KW - Psychopharmacology

KW - Safety

KW - Selective serotonin reuptake inhibitors

UR - http://www.scopus.com/inward/record.url?scp=0032906439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032906439&partnerID=8YFLogxK

M3 - Article

C2 - 10230183

AN - SCOPUS:0032906439

VL - 38

SP - 517

EP - 528

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 5

ER -